Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > About Breakthrough T1D UK & our impact > Our research
One day, we will create a world without type 1 diabetes. Until that day, your support is vital for our international research to cure, treat and prevent type 1.
We fund international research that will cure, treat and prevent type 1 diabetes and its complications. We focus on investing in research that will transform the lives of people with type 1 diabetes – improving treatments today until we find a cure.
Over 450 active research studies are being funded by Breakthrough T1D around the world.
Breakthrough T1D-funded research is currently taking place in over 20 countries.
At any one time, we are funding around 30 research projects in the UK.
Discover how we’re working to cure, treat and prevent type 1 diabetes
Our researchers are working on lots of different ways to develop a cure for type 1 diabetes, from growing insulin-producing beta cells in labs to hacking the immune system to stop it attacking beta cells.
We’re improving lives by developing new ways to treat type 1 diabetes, until we find a cure. Our treatment research includes advancing technologies to help people with type 1 manage their blood glucose levels, creating new and improved types of insulin, and tackling diabetes complications.
Our prevention research aims to fix the problems with the immune system that lie at the heart of the condition. We’re also supporting screening projects to find people in the earliest stages of developing type 1 and delay their need for insulin injections.
The US FDA recently approved a drug that can delay the onset of type 1 diabetes for up to three years, called teplizumab. This success wouldn’t have happened without 30 years of Breakthrough T1D UK funding research.
Since 2006, we have funded research to develop and test hybrid closed loop (HCL) technology, which links people's insulin pump to their continuous glucose monitor. Now, HCL is set to become available to many people on the NHS.
For over 20 years, we funded Professor Doug Melton to grow stem cells into insulin-producing beta cells. Doug now works at Vertex Pharmaceuticals, who are running a clinical trial transplanting Doug’s lab-grown beta cells into people with type 1.
Dr Rachel Sumner and her team at the University of Bristol are investigating diabetes burnout, and how better to understand it. Diabetes burnout affects around one third of people with type 1 diabetes (T1D), and although known about, it is poorly understood. The researchers aim to find investigate the biological and psychosocial impacts of diabetes burnout, to further help future studies.
Dr Rachael Hughson-Gill is a researcher at the University of Lincoln, who is studying how body image issues affect young women with type 1 diabetes (T1D).
Dr Gordon Sloan and his team at the University of Sheffield are researching a new method to identify nerve pain (neuropathy) in teens and young adults with type 1 diabetes (T1D).
Dr Tom Wylie’s pioneering research project investigating the psychological impact of type 1 diabetes (T1D), in partnership with the Daphne Jackson Trust.
Dr Kathleen Gillespie and her team are researching how signalling molecules help coordinate immune cell attacks on the pancreas, contributing to T1D development.
Dr Kathleen Gillespie and her team will investigate whether existing tests could help predict how quickly a person in the early stages of T1D will progress.
Dr Matthew Anson is studying whether hybrid closed loop technology, also known as an artificial pancreas, affects the worsening of diabetic eye disease.
Dr Samet Sahin is developing a simple tool to allow healthcare professionals to quickly and easily check someone’s C-peptide levels, a measure of how much insulin they are releasing.
Learn about clinical trials, how to get involved in the different kinds of type 1 diabetes research and view current opportunities.
Dr Rachel Besser, Consultant and Research Lead at Oxfordshire Children’s Diabetes Service, and researcher at the University of Oxford, on how teplizumab being approved in the US benefits children in the UK.
Globally, we have invested over £2 billion in research to date and are currently funding more than 400 research projects and 19 clinical trials. Breakthrough T1D UK has several funding opportunities available that address our mission to cure, treat and prevent type 1 diabetes.
We are delighted with the decision to approve teplizumab for use on the NHS.
You may have heard of a new feature called ‘CamAPS Liberty’, which will soon be available on the CamAPS FX app. This ‘fully closed-loop’ (FCL) mode, when activated; will allow users to remove the need to count carbohydrates before a meal. But what does this mean for people with type 1 diabetes (T1D), and how close are we to removing meal announcement altogether? Here is what we know…
New data presented this week at the American Diabetes Association’s (ADA) 86th Scientific Sessions shows incredible promise: all 12 participants in the Eledon trial, testing the immunosuppressive drug tegoprubart, are no longer injecting insulin.
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
We work with researchers and partner organisations to make sure we can improve life with type 1 diabetes as quickly as possible. Learn about the research we do in partnership with other organisations.
Discover how we work with other organisations to help us make every penny we receive from our amazing supporters go even further to help people with type 1.
Learn about how we're partnering with other autoimmune research funders, pooling our resources to help prevent and cure a range of autoimmune conditions, including type 1 diabetes.
The Type 1 Diabetes Grand Challenge is a partnership between the Steve Morgan Foundation, Diabetes UK and Breakthrough T1D UK. We are united by our ambition to cure type 1 diabetes.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
